ClinicalTrials.Veeva

Menu

Tramadol and Pain Sensitization (TRAMADOL)

U

University Hospital, Clermont-Ferrand

Status and phase

Completed
Phase 1

Conditions

Pain

Treatments

Drug: Tramadol

Study type

Interventional

Funder types

Other

Identifiers

NCT00487175
CHU63-0020

Details and patient eligibility

About

Tramadol is a largely used analgesic drug. Its role however on sensitization as occurs for example in neuropathic pain is not very well known. This protocol aims therefore at studying the effect of tramadol in a human pain model with sensitization induced by a cold stimulus, using evoked potentials to elucidate how pain is modified when tramadol is administered.

Full description

The study is a comparison of the analgesic of tramadol versus placebo in a pain model using evoked potentials. Evaluation criteria will be the amplitude of the evoked potential obtained defore and after treatment

Enrollment

12 estimated patients

Sex

Male

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy men
  • Between 18 and 40 years old
  • Written consent given

Exclusion criteria

  • Concomitant medication
  • Tramadol hypersensibility
  • Excessive consumption of alcohol, tobacco, coffee, tea or toxicomania

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems